DCOY Decoy Therapeutics Inc.
Company Analysis
Latest News
🔴 Decoy Therapeutics is trading 5.7% down with no clear catalyst identified
Decoy Therapeutics is trading 5.7% down at $1.75, with no clearly identified catalyst for the October 2 decline. - The latest preclinical update was reported...
🔴 Decoy Therapeutics is trading 5% down in pre-market amid mixed biotech-sector signals
Decoy Therapeutics is trading 5.12% down at $1.76, with no fresh company-specific announcement identified to explain the October 2 pre-market decline. - The...
🔴 Decoy Therapeutics is trading 7.6% down with no clear company-specific catalyst identified
Decoy Therapeutics is trading 7.6% lower at $1.82, with no clear company-specific catalyst identified for the October 1 decline. - The CEO presentation at The...
🔴 Decoy Therapeutics is trading 5.6% down with no clear catalyst identified
Decoy Therapeutics is trading at $2.01, down 5.63%; no clear catalyst was identified for the September 30 decline. - The company announced its CEO will present...
🔴 Decoy Therapeutics is trading 11% down
Decoy Therapeutics is trading at $2.06, down 10.61%, with no clear catalyst established for the decline. - On September 29, Decoy Therapeutics announced...
🔴 Decoy Therapeutics is trading 5% down
Decoy Therapeutics is trading at $2.19, down 5.41%, with no clear catalyst established. - September 29 preclinical data showed a single intranasal dose...
🟢 Decoy Therapeutics is trading 7.2% up in after-hours trading
Decoy Therapeutics is trading 7.2% higher at $2.48 after hours, with no fresh company-specific announcement identified to explain the rebound. - The stock...
🔴 Decoy Therapeutics is trading 10.68% down amid broader risk-off pressure
Decoy Therapeutics is trading at $2.76, down 10.68% on September 28, 2026, amid broader risk-off pressure; no fresh company-specific catalyst was...
🔴 Decoy Therapeutics is trading 9.39% down with no fresh company-specific catalyst identified
Decoy Therapeutics is trading 9.39% lower at $2.80, with no fresh company-specific catalyst identified for the September 28 decline. - The available alert...
🔴 Decoy Therapeutics is trading 6.8% down in pre-market with no company-specific catalyst identified
Decoy Therapeutics is trading at $2.88, down 6.80%, with no fresh company-specific catalyst identified for the September 28 pre-market drop. - Broader...
🟢 Decoy Therapeutics is trading 5.79% up in after-hours trading after warrant financing raised about $3.85 million
Decoy Therapeutics is trading 5.79% up at $3.29 in after-hours trading after warrant-inducement financing delivered approximately $3.85 million in gross...
🔴 Decoy Therapeutics is trading 11.43% down today as immediately exercisable warrants intensify dilution pressure
Decoy Therapeutics is trading 11.43% lower at $3.41 after its September 23, 2026 warrant-inducement financing created dilution pressure. - The transaction...
🔴 Decoy Therapeutics is trading 8.31% down today as immediately exercisable warrants add dilution pressure
Decoy Therapeutics is trading 8.31% down at $3.53, with the warrant-inducement financing creating the clearest pressure. - Shares are pulling back after...
🔴 Decoy Therapeutics is trading 7.4% down today in pre-market amid warrant-inducement financing overhang
Decoy Therapeutics is trading 7.4% down now in pre-market at $3.56, with warrant-inducement financing overhang following a sharp two-session rally. - The $3.85...
Decoy Therapeutics Raises $3.85M via Warrant Inducement Transaction
Decoy Therapeutics Inc. entered into a warrant inducement agreement with an institutional investor, raising approximately $3.85 million in gross proceeds. The...
🟢 Decoy Therapeutics is trading 48.71% up today after announcing a pan-filovirus antiviral program
Decoy Therapeutics is trading 48.71% up at $4.61 after announcing a pan-filovirus antiviral program on September 22, 2026, targeting Ebola and Marburg viruses...
🟢 Decoy Therapeutics is trading 19% up in pre-market after announcing pan-filovirus antiviral program
Decoy Therapeutics is trading at $3.69, up +19.03%, after announcing a pan-filovirus antiviral program targeting Ebola and Marburg viruses. - The program is...
🟢 Decoy Therapeutics is trading 12.58% up in after-hours trading after announcing a pan-filovirus antiviral program
Decoy Therapeutics is trading 12.58% up at $3.49 after announcing a pan-filovirus antiviral program targeting Ebola and Marburg viruses through the FDA’s...
🟢 Decoy Therapeutics is trading 7% up in after-hours trading after announcing its Ebola-Marburg antiviral program
Decoy Therapeutics is trading 7.10% higher at $3.32 after announcing a pan-filovirus program targeting Ebola and Marburg viruses through the FDA’s Animal Rule...
Decoy Therapeutics Doubles on an Ebola Drug Bet — But Can a Micro-Cap With 11 Employees Actually Deliver?
Shares of Decoy Therapeutics (DCOY) exploded +131% to $5.92 on September 22, after the Cambridge-based biotech unveiled a plan to develop a broad antiviral...